Crio Receives Investment from The Riverside Company

Crio, a Boston, Ma-based provider of eSource and other eClinical technologies, received an investment from The Riverside Company.

The amount of the deal was not disclosed.

The company intends to use the funds to accelerate the expansion of its product roadmap to further enhance its value proposition to clinical research sites, biopharmaceutical companies and CROs.

Co-founded by co-CEOs Raymond Nomizu and Jonathan Andrus, Crio is a provider of eSource and other eClinical technologies. Its eClinical platform is designed to streamline research at the site-level, with fully integrated eSource, site CTMS, eConsent, EDC, remote monitoring, and source data verification solutions.